Kazinol A

CAS No. 99624-28-9

Kazinol A( ——— )

Catalog No. M38936 CAS No. 99624-28-9

Kazinol A induces cytotoxic effects in human bladder cancer cells, including the cisplatin-resistant T24R2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1493 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Kazinol A
  • Note
    Research use only, not for human use.
  • Brief Description
    Kazinol A induces cytotoxic effects in human bladder cancer cells, including the cisplatin-resistant T24R2.
  • Description
    Kazinol A shows strong inhibition of arachidonic acid (AA)-induced platelet aggregation. It also exhibits potent inhibition with IC50 values ranging 0.6-164 M against XOD.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AKT-BAD;AMPK;mTOR;p21;T24R2;XOD
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    99624-28-9
  • Formula Weight
    394.5
  • Molecular Formula
    C25H30O4
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Park S, et al. Cytotoxic effects of kazinol A derived from Broussonetia papyrifera on human bladder cancer cells, T24 and T24R2.?Phytomedicine. 2016;23(12):1462-1468.??
molnova catalog
related products
  • ETC-1002

    A small molecule regulator of lipid and carbohydrate metabolism that targets ACC (acetyl-CoA carboxylase) with IC50 of 29 uM.

  • GSK621

    GSK621 (GSK-621) is a potent, specific AMPK agonist (activator), induces cytotoxicity in AML (IC50=13-30 uM).

  • Metformin

    Metformin is an AMP-activated protein kinase (AMPK) activator that improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose.